Exenatide-Induced Urticaria: A Case Report and Review of the Literature

World Allergy Organization Journal 2026 Open access

Read full text
Authors: Reem Faiz Hussein Eisa, Marwa Elaziz, Vajeeha Haider, Abdullah Mohamed M. Elsafti Elsaeidy
DOI: 10.1016/j.waojou.2026.101263
Cited by: 0
References: 2

Abstract

Exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, represents an important therapeutic option for patients with type 2 diabetes mellitus (T2DM) due to its documented efficacy in improving glycemic control, promoting weight loss, and providing cardiovascular benefits. While gastrointestinal symptoms are commonly encountered with this class of agents, systemic hypersensitivity reactions, including urticaria and anaphylaxis, are considered rare but may result in significant morbidity when they occur.

Fields of Study & Subjects

Drug-Induced Adverse Reactions Urticaria and Related Conditions Food Allergy and Anaphylaxis Research

Publication details

Journal / source
World Allergy Organization Journal
Volume
19
Issue
2
Pages
101263–101263
Publication date
1 February 2026
Language
EN